Friday, May 24, 2019 3:28:45 PM
After Kraig proves mass production (say their first metric ton), what other question marks are left that would be holding this company back from becoming a multi billion dollar company? I tried but it seemed pretty nit picky.
1. Buyers/demand? They have at least 2 willing buyers in Polartec and the DOD, capacity was the only issue.
2. Their raw source material? They have the contracts with Vietnamese co-ops which plan on increasing mulberry planting to ~2500ha. Their should be plenty of mulberry in that region for quite some time.
3. Financing maybe? we have the bridge loan, but we don't know much after that. But if kraig starts selling silk at a premium, that could create decent cash flow for Vietnam operations.
My point is; Once Kraig PR's mass production, is the share price going to jump to multiple dollars and stay there? is that really what everyone is waiting for before they buy in and hold? To me that shows a lack of forward thinking because I have no doubt in my mind that Kraig will produce tons. I can't believe the share price doesn't reflect the very very high probability that this company will produce. It took a while, but it will. I've held this company since 2010, but once they got into vietnam, i new it was game time.
What questions will people still NEED answers to to have confidents that this company will succeed?
Just my opinion and would love others with honest feedback
Recent KBLB News
- Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend] • Edgar (US Regulatory) • 11/22/2023 09:31:54 PM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 11/16/2023 09:30:34 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/13/2023 09:43:51 PM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 09/11/2023 08:30:50 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 09/08/2023 04:15:15 AM
- Form POS AM - Post-Effective amendments for registration statement • Edgar (US Regulatory) • 09/01/2023 08:30:52 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/14/2023 08:35:05 PM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM